2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Injection Site Irritation: new trials by email Literature Review of Injection Site Irritation trials Research Report on Injection Site Irritation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial Ondansetron, Lidocaine - Injection Site Irritation | Phase 2 | Terminated | Emory University | 6 | 2023-05-18 | 2026-04-24 |
| Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Lidocaine, Esmolol, Placebo - Injection Site Irritation, Pain | Phase 2 / Phase 3 | Terminated | Wake Forest University Health Sciences | 33 | 2020-09-09 | 2024-09-19 |
Pain (1)
Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Lidocaine (2) · Injections (1) · Ondansetron (1) · esmolol (1)
Emory University (1) · Wake Forest University Health Sciences (1)
United States (2)
Michael Norton, MD (1) · Vipin Bansal, MD (1)